If clinicians use machine learning predictive models to assist with prognosis, should they disclose this to patients?
A patient schedules a visit with her internal medicine physician to discuss results of a direct-to-consumer (DTC) genetic test. How should the physician respond to the patient’s questions, given the report’s technical detail about specific genetic information outside most generalist physicians’ expertise?
Our editorial mission is to help medical students, physicians, and all health care professionals make sound ethical decisions in service to patients and society. Founded in 1999, the AMA Journal of Ethics explores ethical questions and challenges that students and clinicians confront in their educational and practice careers.